----

| [X] | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 |
|-----|----------------------------------------------------------------------------------------------------------------------------------|

| Nevada                                                         | 98-0542529                           |
|----------------------------------------------------------------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to section 12(g) of the Act: |
|-------------------------------------------------------------|-------------------------------------------------------------|
| None(Title of Class)                                        | Common Stock(Title of Class)                                |

|   | Large Accelerated Filer                       | [   ] | Accelerated Filer          | [   ] |
|--------|-----------------------------------------------|-----------------|---------------------------------|-----------------|
|   | Non-accelerated Filer                         | [   ] | Smaller Reporting Company  | [X]             |
|   | (Do not check if a smaller reporting company) |

----

----

|          |                                                                                                 | Page   |
|---------------|------------------------------------------------------------------------------------------------------|--------|
|          |                                                                                                 |   |
|          | PART I                                                                                               | 3      |
|          |                                                                                                 |   |
| Item 1.       | Business.                                                                                            | 3      |
| Item 1A.      | Risk Factors.                                                                                        | 6      |
| Item 1B.      | Unresolved Staff Comments.                                                                           | 7      |
| Item 2.       | Properties.                                                                                          | 7      |
| Item 3.       | Legal Proceedings.                                                                                   | 7      |
| Item 4.       | Mine Safety Disclosures.                                                                             | 7      |
|          |                                                                                                 |   |
|          | PART II                                                                                              | 7      |
|          |                                                                                                 |   |
| Item 5.       | Market for Our Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. | 7      |
| Item 6.       | Selected Financial Data.                                                                             | 8      |
| Item 7.       | Management's Discussion and Analysis of Financial Condition and Results of Operations.               | 9      |
| Item 7A.      | Quantitative and Qualitative Disclosures about Market Risk.                                          | 15     |
| Item 8.       | Financial Statements and Supplementary Data.                                                         | 16     |
| Item 9.       | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.                | 40     |
| Item 9A.      | Controls and Procedures.                                                                             | 41     |
| Item 9B.      | Other Information.                                                                                   | 42     |
|          |                                                                                                 |   |
|          | PART III                                                                                             | 42     |
|          |                                                                                                 |   |
| Item 10.      | Directors, Executive Officers and Corporate Governance.                                              | 42     |
| Item 11.      | Executive Compensation.                                                                              | 45     |
| Item 12.      | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.      | 47     |
| Item 13.      | Certain Relationships and Related Transactions, and Director Independence.                           | 48     |
| Item 14.      | Principal Accountant Fees and Services.                                                              | 48     |
|          |                                                                                                 |   |
|          | PART IV                                                                                              | 50     |
|          |                                                                                                 |   |
| Item 15.      | Exhibits and Financial Statement Schedules.                                                          | 50     |
|          |                                                                                                 |   |
| Signatures    | 53                                                                                                   |
|          |                                                                                                 |
| Exhibit Index | 54                                                                                                   |

----

| 1. | Care Platforms |
|----|----------------|

| a. | These include the care facility platforms – MobileCareTM and RuralCareTM described in more detail in the MD&A section, Dialysis care and brick and mortar hospitals as well as the emergency medical services care both land and air transportation. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Digital Technology |
|----|--------------------|

| a. | This component of the business includes the Electronic Medical Records (EMR), Picture Archiving and Communication System (PACS), eLearning system, eGovernance solutions as well as our Tele-health solution that supports the Global and Regional response centers for real time support of medical emergencies. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Education & Training |
|----|--------------------------|

| a. | This component includes the education and training for all aspects of healthcare management – clinical including clinical informatics, engineering including bio-medical, information and communications technology and health administration. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| A. | M.C. Telehealth – Mobile Clinic Telehealth System – Developed and launched in November 2011. |
|----|----------------------------------------------------------------------------------------------------------|

| B. | EMR Integration Engine – Electronic Medical Record Integration Engine - Under development. |
|----|--------------------------------------------------------------------------------------------------|

| C. | C&ID-IMS – Communicable and Infectious Disease Information Management System - Under Development |
|----|------------------------------------------------------------------------------------------------------------|

| D. | CCG Technology – Clinical-Care Globalization technology – Under Development |
|----|-----------------------------------------------------------------------------------------|

----

| Number  | Date of Filing    | Place of Filing | Duration                                                                                                                                          |
|---------|-------------------|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------|
| 1072203 | November 3, 2009  | Canada          | Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year |
| 1072204 | November 3, 2009  | Canada          | Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year |
| 1072205 | November 3, 2009  | Canada          | Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year |
| 1072543 | November 17, 2009 | Canada          | Life of the Author, the remainder of the calendar year in which the author dies, and a period of 50 years following the end of that calendar year |

| 1. | The company has proprietary Copyrighted Technology "EMR Integration Engine" that demonstrate the future direction for integrated solutions as well as current efforts that illustrate interoperability within the continuum of care. EMR Integration Engine is software, which connects all the other applications in or outside a hospital/clinic with the EMR system. This enables the doctor/nurse to seamlessly access information in other healthcare applications without moving from one computer to the next. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | C&ID-IMS is an Internet-based solution for monitoring and managing Communicable and Infectious Disease information. Our target markets are Health Organizations and Ministries of Health, hospitals and Center for Disease Control (CDC) & the World Health Organization (WHO) members around the globe. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | CCG is our clinical-care globalization technology. This product is an effective way to capitalize on the growing "medical tourism phenomenon " - patients going to low-cost countries for elective medical procedures –, a fast-growing worldwide, multibillion-dollar industry actively promoted by many countries. CCG can be used by both the destination and home country of a patient to maintain complete and accurate records of the treatment history, avoiding errors due to incomplete patient data and lessening the burden and expense of corrective action on the home country when medical tourists return home. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | MC-Telehealth (Mobile Clinic with Telehealth system) is our mobile clinic long distance or Telehealth technology. Our product enables the remote transmission of standardized formats of data for laboratory information, diagnostic imaging, diagnosis and clinical notes. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | KIDS (Kallo Integrated Delivery System), a Technology & process framework defines and describes the component parts of the various products and services that Kāllo is delivering to its clients, including the human resources component, and how these parts interact and relate to one another.  The framework also recognizes the need for collaboration with local care facilities, services and providers to support continuity of care and facilitate patient transport between facilities. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | KIDS (Kallo Integrated Delivery System) Global Tele-Health Ecosystems. The Tele-health Program encompasses the broad variety of Technologies and administrative processes needed to deliver virtual medical care, health promotion/prevention and other patient education to KIDS patients. The tele-health program facilitates synchronous and asynchronous interactions where patients or care providers are in different locations and includes scheduling, information delivery and care management services. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| · | Communicable & Infectious disease Information Management System – supporting World Health Organization (WHO) and Center for Disease Control (CDC); $200B market |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Electronic Medical Records integration engine for Health Information Access Layer – focused on clinics, hospitals, IDC & IHC; $100B market |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Clinical Care Globalization – focused on medical tourism; $40B market |
|--------|-----------------------------------------------------------------------------|

| · | Mobile Medical Clinics – focused on disaster recovery management and rural community health services for wide range of services, HIV monitoring, chemotherapy, acute care, dialysis, etc; $30B market |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| ITEM 5. | MARKET FOR OUR COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
|---------|-----------------------------------------------------------------------------------------------------|

|   | Fiscal Year2015 | High Bid                           | Low Bid |    |
|--------|-----------------|------------------------------------|---------|---------|
|   |            | Fourth Quarter 10-1-15 to 12-31-15 | $0.0011 | $0.0001 |   |
|   |            | Third Quarter 7-1-15 to 9-30-15    | $0.035  | $0.0008 |   |
|   |            | Second Quarter 4-1-15 to 6-30-15   | $0.15   | $0.265  |   |
|   |            | First Quarter 1-1-15 to 3-31-15    | $0.11   | $0.0462 |   |

|   | Fiscal Year2014 | High Bid                           | Low Bid |    |
|--------|-----------------|------------------------------------|---------|---------|
|   |            | Fourth Quarter 10-1-14 to 12-31-14 | $0.25   | $0.025  |   |
|   |            | Third Quarter 7-1-14 to 9-30-14    | $0.08   | $0.0401 |   |
|   |            | Second Quarter 4-1-14 to 6-30-14   | $0.11   | $0.0301 |   |
|   |            | First Quarter 1-1-14 to 3-31-14    | $0.45   | $0.03   |   |

----

| Plan category                      | Number of securities tobe issued upon exerciseof outstanding options,warrants and rights(a) | Weighted-averageexercise price ofoutstanding options,warrants and rights(b) | Number of securities remainingavailable for future issuanceunder equity compensation plans(excluding securities in column (a))(c) |
|------------------------------------|---------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|
| Equity compensation plans          |                                                                                        |                                                                        |                                                                                                                              |
| approved by security holders       | None                                                                                        | None                                                                        | None                                                                                                                              |
|                               |                                                                                        |                                                                        |                                                                                                                              |
| Equity compensation plans          |                                                                                        |                                                                        |                                                                                                                              |
| not approved by securities holders | 0                                                                                           | $0.0                                                                        | 52,766,666                                                                                                                        |
|                               |                                                                                        |                                                                        |                                                                                                                              |
| Total                              | 0                                                                                           | $0.0                                                                        | 52,766,666                                                                                                                        |

----

| ITEM 7. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
|---------|----------------------------------------------------------------------------------------|

----

| 1. | Mobile clinics                                        - (10) |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Clinical Command Centre - (1) |
|----|-------------------------------|

| 3. | Administration Centre -                                                      (1) |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Utility vehicles - (2) |
|----|------------------------|

| 5. | User training - (5 years) |
|----|---------------------------|

| 6. | Professional and clinical training - (5 years) |
|----|------------------------------------------------|

| 7. | Hardware and software maintenance - (5years) |
|----|----------------------------------------------|

| 8. | Operations & management support - (5 years) |
|----|-------------------------------------------------|

| 9. | Maintenance and continued educational support - (5 years) |
|----|-----------------------------------------------------------|

| 10. | Supply chain management of medical equipment, consumables and spare parts - (5 years) |
|-----|---------------------------------------------------------------------------------------|

| 11. | Advanced and integrated software systems, including telehealth - (1 full system) |
|-----|----------------------------------------------------------------------------------|

| 12. | Fixed Medical Hospital - (1) |
|-----|------------------------------|

| 13. | Ambulances - (20) |
|-----|-------------------|

| 14. | Medical Helicopter - (1) |
|-----|--------------------------|

| 1. | Mobile Clinics (2) |
|----|--------------------|

| 2. | Utility Vehicle (1) |
|----|---------------------|

| 3. | Clinical, Pharmaceutical and Laboratory Equipment |
|----|---------------------------------------------------|

| 4. | Networking & Communications Infrastructure |
|----|------------------------------------------------|

| 5. | Clinical Systems |
|----|------------------|

| 6. | 5-Year Service & Maintenance |
|----|----------------------------------|

| 7. | 5-Year Education & Training by Kallo University |
|----|-----------------------------------------------------|

| 8. | Freight & Insurance |
|----|-------------------------|

----

|               | PolyclinicUrban-Urban | PolyclinicRural- Rural | Total | CHPS |
|--------------------|-----------------------|------------------------|-------|------|
| Greater Accra      | 3                     | 1                      | 4     | 0    |
| Ashanti Region     | 2                     | 1                      | 3     | 0    |
| Central Region     | 2                     | 1                      | 3     | 2    |
| Northern Region    | 2                     | 2                      | 4     | 2    |
| Upper East Region  | 1                     | 2                      | 3     | 2    |
| Upper West Region  | 0                     | 0                      | 0     | 1    |
| Western Region     | 2                     | 3                      | 5     | 0    |
| Volta Region       | 1                     | 1                      | 2     | 2    |
| Eastern Region     | 1                     | 1                      | 2     | 0    |
| Brong-Ahafo Region | 1                     | 0                      | 1     | 1    |
|               | 15                    | 12                     | 27    | 10   |

| · | MobileCareTM – a mobile trailer that opens into a state of the art clinical setup in a vehicle equipped with the latest technology in healthcare.   More than just a facility, MobileCareTM can instantly connect the onboard physician with specialists for on-demand consultation via satellite through its Telehealth system. This is truly a holistic approach to delivering healthcare to the remotely located. For many rural communities, the nearest hospital, doctor or nurse may be hundreds of kilometers away. In many cases, this gap can be bridged using Telehealth technology that allows patients, nurses and doctors to talk as if they were in the same room. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | RuralCareTM – prefabricated modular healthcare units focused in rural areas where no roads infrastructure is available.  They are equipped to provide primary healthcare including X-Ray, ultrasound, surgery, pharmacy and lab services.  Ranging from 1,200 to 3,800 square feet, these clinics can be up and running in disaster zones or rural areas in as little as one week.  Similar to the MobileCareTM product, RuralCareTM also utilizes satellite communications to access the Telehealth system. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| · | Global response center – located in the Kallo headquarters in Canada, this is the escalation point for the coordination of delivery of Telehealth and eHealth support. It consists of both the Clinical Command Center and the Administrative Command Center. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Regional response centers, Clinical and Administrative Command centers – located in the urban area hospitals and connected with satellite communications, these centers coordinate all aspects of the healthcare delivery solution with the Mobile clinics and Rural clinics including clinical services, Telehealth services, pharmacy and medical consumable coordination as well as escalations to the Global response center. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Kallo University – provides education, training and development of local resources for all aspects of the healthcare delivery which includes clinical, engineering and administration. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Emergency Services – provides ground and air ambulance vehicles for emergency transport.   |
|--------|------------------------------------------------------------------------------------------------------------|

| 1. | Full solution with Kallo Integrated Delivery System (KIDS) – typically longer sales cycle and includes the end to end solution of Mobile Clinics, Rural Poly Clinics, Global and Regional response centers, Clinical and Administrative command centers, telehealth support, Kallo University training, pharmacy and medical consumable support and Emergency services with ground and air ambulance vehicles.  This solution is focused on the end to end healthcare needs of developing countries. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Component Solutions – typically mid-term sales cycle and includes any of the components of the KIDS implementation without the full support structure.  This strategy is focused on augmenting healthcare support where needed, such as, disaster management, North American First Nations, medical equipment supply, installation and testing. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Technology Solutions – typically short-term sales cycle and includes elements of the KIDS program that can enhance existing healthcare solutions.  These would include our Hospital Management System, Consulting services, Bio Medical support, Mobile or Fixed Clinic manufacturing, etc.  This strategy is focused on enhancing existing healthcare environments globally. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1. | Develop our sales and marketing organization for the Component Solutions segment and expand the existing pipeline by building relationships with Government disaster recovery agencies as well as First Nations Leaders.  We are utilizing existing resources to execute this strategy and will expand as operational financing permits. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Perform a market analysis of the demand for individual components of the solution and targeted audience for each of the components.  We are utilizing the expertise of existing resources to execute this strategy and will expand as operational financing permits. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 3. | Continue to develop a pipeline of qualified opportunities for the full delivery solution with target to close and begin execution of the solution within the next 12 months. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1. | Establish geographical coverage for Mobile Clinics based on hospitals to population ratio in specific rural areas of Guinea |
|----|-----------------------------------------------------------------------------------------------------------------------------|

| 2. | Establish the specialists support from teaching hospitals |
|----|-----------------------------------------------------------|

| 3. | Finalize all in country support contracts |
|----|-------------------------------------------|

| 4. | Establish in country leadership for operational and administrative support |
|----|----------------------------------------------------------------------------|

| 5. | Establish governance councils for operations, education and training |
|----|----------------------------------------------------------------------|

| · | Currently in discussions with Minister of Health to determine scope of a direct add on to the Chrispod Limited contract for medical equipment expansion for existing healthcare facilities across Ghana.  Request for proposal and decision is expected by end of May 2016. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

|                                                                                   | PAGE    |
|----------------------------------------------------------------------------------------|---------|
|                                                                                   |    |
| Report of Independent Registered Public Accounting Firm for December 31, 2015 and 2014 | 17      |
|                                                                                   |    |
| Consolidated Balance Sheets                                                            | 18      |
|                                                                                   |    |
| Consolidated Statements of Operations                                                  | 19      |
|                                                                                   |    |
| Consolidated Statements of Changes in Stockholders' Equity (Deficiency)                | 20      |
|                                                                                   |    |
| Consolidated Statements of Cash Flows                                                  | 21      |
|                                                                                   |    |
| Notes to Consolidated Financial Statements                                             | 22 - 39 |

----

| MALONEBAILEY, LLP |   |
|-------------------|--------|
| Houston, Texas    |   |
| April 14, 2016    |   |

----

|                                                                                                                                        |   | 2015   |        |   | 2014   |   |
|---------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-------------|--------|--------|--------|
| ASSETS                                                                                                                                      |   |   |        |   |   |   |
| Current Assets:                                                                                                                             |   |   |        |   |   |   |
| Cash                                                                                                                                        |   | $      | 4,998       |   |   | $      | 250,339 |   |
| Other receivables                                                                                                                           |   |   | -           |   |   |   | 11,531 |   |
| Deferred project costs                                                                                                                      |   |   | -           |   |   |   | 24,990 |   |
| Prepaid expenses                                                                                                                            |   |   | 132,259     |   |   |   | 122,022 |   |
| Total Current Assets                                                                                                                        |   |   | 137,257     |   |   |   | 408,882 |   |
|                                                                                                                                        |   |   |        |   |   |   |   |   |
| Deposit – long term                                                                                                                   |   |   | 20,627      |   |   |   | 49,220 |   |
| Equipment, net                                                                                                                              |   |   | 135,551     |   |   |   | 98,241 |   |
| TOTAL ASSETS                                                                                                                                |   | $      | 293,435     |   |   | $      | 556,343 |   |
|                                                                                                                                        |   |   |        |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                    |   |   |        |   |   |   |   |   |
| Current Liabilities:                                                                                                                        |   |   |        |   |   |   |   |   |
| Accounts payable and accrued liabilities                                                                                                    |   | $      | 1,204,942   |   |   | $      | 924,494 |   |
| Loans payable                                                                                                                               |   |   | -           |   |   |   | 56,112 |   |
| Derivative liabilities                                                                                                                      |   |   | 210,834     |   |   |   | 336,390 |   |
| Convertible promissory notes net of discount of $69,568 and $248,825 respectively                                                           |   |   | 204,826     |   |   |   | 16,175 |   |
| Convertible loans payable – third parties                                                                                             |   |   | 105,395     |   |   |   | - |   |
| Short term loans payable                                                                                                                    |   |   | 15,730      |   |   |   | 38,555 |   |
| Convertible loans payable – related parties                                                                                           |   |   | 272,712     |   |   |   | - |   |
| Deferred lease inducement                                                                                                                   |   |   | 15,380      |   |   |   | 35,181 |   |
| Deferred revenue                                                                                                                            |   |   | -           |   |   |   | 24,990 |   |
| Total Current Liabilities                                                                                                                   |   |   | 2,029,819   |   |   |   | 1,431,897 |   |
|        Convertible promissory notes, net of discount $59,939 and NIL respectively                        |   |   | 24,551      |   |   |   |   |   |
| TOTAL LIABILITIES                                                                                                                           |   |   | 2,054,370   |   |   |   | 1,431,897 |   |
|                                                                                                                                        |   |   |        |   |   |   |   |   |
| Commitments and Contingencies                                                                                                               |   |   |        |   |   |   |   |   |
|                                                                                                                                        |   |   |        |   |   |   |   |   |
| Stockholders' Deficiency:                                                                                                                   |   |   |        |   |   |   |   |   |
| Preferred stock, $0.00001 par value, 100,000,000 shares authorized,95,000,000 Series A preferred shares issued or outstanding               |   |   | 950         |   |   |   | 950 |   |
| Common stock, $0.00001 par value, 15,000,000,000 sharesauthorized, 5,648,390,746 and 382,156,160 shares issuedand outstanding respectively. |   |   | 56,485      |   |   |   | 3,822 |   |
| Additional paid-in capital                                                                                                                  |   |   | 30,324,674  |   |   |   | 22,297,758 |   |
| Accumulated deficit                                                                                                                         |   |   | (32,143,044 | )      |   |   | (23,178,084 | ) |
|                                                                                                                                        |   |   |        |   |   |   |   |   |
| Total Stockholders' Deficiency                                                                                                              |   |   | (1,760,935  | )      |   |   | (875,554 | ) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                              |   | $      | 293,435     |   |   | $      | 556,343 |   |

----

|                                                             |   | For the Year |        |   | For the Year |   |
|------------------------------------------------------------------|--------|--------------|-------------|--------|--------------|--------|
|                                                             |   | Ended        |        |   | Ended        |   |
|                                                             |   | December 31, |        |   | December 31, |   |
|                                                             |   | 2015         |        |   | 2014         |   |
|                                                             |   |         |        |   |         |   |
| Expenses                                                         |   |         |        |   |         |   |
| General and administration                                       |   |         | 7,434,862   |   |         |   | 2,953,330 |   |
| Selling and marketing                                            |   |         | 230,165     |   |         |   | 246,127 |   |
|                                                             |   |         |        |   |         |   |   |   |
| Foreign exchange (gain) loss                                     |   |         | (66,093     | )      |         |   | (53,827 | ) |
| Depreciation                                                     |   |         | 76,457      |   |         |   | 53,813 |   |
| Interest and financing costs                                     |   |         | 948,607     |   |         |   | 45,878 |   |
| Change in fair value on derivative liabilities                   |   |         | (97,890     | )      |         |   | 95,293 |   |
| Impairment of copyrights / Assets                                |   |         | 355,508     |   |         |   | 865,000 |   |
| Loss on extinguishment of short term loan payable                |   |         | 83,344      |   |         |   | 3,424 |   |
|                                                             |   |         | 8,964,960   |   |         |   | 4,209,038 |   |
|                                                             |   |         |        |   |         |   |   |   |
| Net Loss and comprehensive loss                                  |   | $            | (8,964,960  | )      |         | $      | (4,209,038 | ) |
|                                                             |   |         |        |   |         |   |   |   |
| Loss per share - Basic and diluted net                           |   | $            | (0.01       | )      |         | $      | (0.01 | ) |
|                                                             |   |         |        |   |         |   |   |   |
| Weighted average number of sharesoutstanding - Basic and diluted |   |         | 966,447,335 |   |         |   | 348,742,260 |   |

----

|                                                          |   |              |       |   |              |   |   |       |   |   | Deficit       |   |   |          |   |
|---------------------------------------------------------------|--------|-------------------|------------|--------|-------------------|--------|--------|------------|--------|--------|---------------|--------|--------|---------------|--------|
|                                                          |   |              |       |   |              |   |   |       |   |   | Accumulated   |   |   |          |   |
|                                                          |   | Preferred Stock   |       |   | Common Stock      |   |   | Additional |   |   | During the    |   |   | Total         |   |
|                                                          |   | $.00001 par value |       |   | $.00001 par value |   |   | Paid-In    |   |   | Development   |   |   | Stockholders' |   |
|                                                          |   | Shares            |       |   | Amount            |   |   | Shares     |   |   | Amount        |   |   | Capital       |   |   | Stage |   |   | Equity (Deficit) |   |
|                                                          |   |              |       |   |              |   |   |       |   |   |          |   |   |          |   |   |   |   |   |   |   |
| Balance December 31, 2013                                     |   |              | -          |   |              | $      | -      |       |   |   | 319,106,020   |   |   | $             | 3,191  |   |   | $ | 18,669,367 |   |   | $ | (18,969,046 | ) |   | $ | (296,488 | ) |
| Issuance of common shares – Kodiak put                  |   |              | -          |   |              |   | -      |       |   |   | 8,472,223     |   |   |          | 85     |   |   |   | 481,498 |   |   |   | - |   |   |   | 481,583 |   |
| Shares issued to directors, employees and others for services |   |              | 95,000,000 |   |              |   | 950    |       |   |   | 7,560,000     |   |   |          | 76     |   |   |   | 721,904 |   |   |   | - |   |   |   | 722,930 |   |
| Settlement of short term loans payableby common shares        |   |              | -          |   |              |   | -      |       |   |   | 680,000       |   |   |          | 7      |   |   |   | 27,193 |   |   |   | - |   |   |   | 27,200 |   |
| Issuance of common shares for cash                            |   |              | -          |   |              |   | -      |       |   |   | 45,637,917    |   |   |          | 456    |   |   |   | 2,281,439 |   |   |   | - |   |   |   | 2,281,895 |   |
| Shares issued and issuable for consulting fees                |   |              | -          |   |              |   | -      |       |   |   | 700,000       |   |   |          | 7      |   |   |   | 116,357 |   |   |   | - |   |   |   | 116,364 |   |
| Net Loss                                                      |   |              | -          |   |              |   | -      |       |   |   | -             |   |   |          | -      |   |   |   | - |   |   |   | (4,209,038 | ) |   |   | (4,209,038 | ) |
| Balance December 31, 2014                                     |   |              | 95,000,000 |   |              |   | 950    |       |   |   | 382,156,160   |   |   |          | 3,822  |   |   |   | 22,297,758 |   |   |   | (23,178,084 | ) |   |   | (875,554 | ) |
| Issuance of common shares – Kodiak put                  |   |              | -          |   |              |   | -      |       |   |   | 6,250,000     |   |   |          | 63     |   |   |   | 172,120 |   |   |   | - |   |   |   | 172,183 |   |
| Shares issued to directors and employees                      |   |              | -          |   |              |   | -      |       |   |   | 2,989,800,000 |   |   |          | 29,898 |   |   |   | 3,671,702 |   |   |   | - |   |   |   | 3,701,600 |   |
| Shares issued for debt conversion                             |   |              | -          |   |              |   | -      |       |   |   | 2,196,251,125 |   |   |          | 21,963 |   |   |   | 1,290,955 |   |   |   | - |   |   |   | 1,312,918 |   |
| Issuance of common shares for cash                            |   |              | -          |   |              |   | -      |       |   |   | 68,867,121    |   |   |          | 689    |   |   |   | 2,490,400 |   |   |   | - |   |   |   | 2,491,089 |   |
| Shares issued for consulting services                         |   |              | -          |   |              |   | -      |       |   |   | 3,508,500     |   |   |          | 35     |   |   |   | 230,392 |   |   |   | - |   |   |   | 230,427 |   |
| Stock issued for settlement of Payables                       |   |              | -          |   |              |   | -      |       |   |   | 1,557,840     |   |   |          | 15     |   |   |   | 171,347 |   |   |   | - |   |   |   | 171,362 |   |
| Net Loss                                                      |   |              | -          |   |              |   | -      |       |   |   | -             |   |   |          | -      |   |   |   | - |   |   |   | (8,964,960 | ) |   |   | (8,964,960 | ) |
| Balance December 31, 2015                                     |   |              | 95,000,000 |   |              | $      | 950    |       |   |   | 5,648,390,746 |   |   | $             | 56,485 |   |   | $ | 30,324,674 |   |   | $ | (32,143,044 | ) |   | $ | (1,760,935 | ) |

----

|                                                                       |   | For the YearEndedDecember 31,2015 |       |   | For the YearEndedDecember 31,2014 |   |
|----------------------------------------------------------------------------|--------|-----------------------------------|------------|--------|-----------------------------------|--------|
| CASH FLOWS FROM OPERATING ACTIVITIES:                                      |   |                              |       |   |                              |   |
| Net loss                                                                   |   | $                                 | (8,964,960 | )      |                              | $      | (4,209,038 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities |   |                              |       |   |                              |   |   |   |
| Depreciation                                                               |   |                              | 76,457     |   |                              |   | 53,813 |   |
| Stock-based compensation                                                   |   |                              | 3,701,600  |   |                              |   | 722,930 |   |
| Impairment of copyrights / assets                                          |   |                              | 355,508    |   |                              |   | 865,000 |   |
| Debt forgiveness                                                           |   |                              | -          |   |                              |   | (31,514 | ) |
| Loss on extinguishment of short term loan payable and accounts payable     |   |                              | 83,344     |   |                              |   | 3,424 |   |
| Amortization of debt discount                                              |   |                              | 780,364    |   |                              |   | 16,175 |   |
| Deferred lease inducement                                                  |   |                              | (19,801    | )      |                              |   | 35,181 |   |
| Change in fair value on derivative liabilities                             |   |                              | (97,890    | )      |                              |   | 95,293 |   |
| Interest and penalties on promissory notes                                 |   |                              | 128,397    |   |                              |   | - |   |
| Unrealized foreign exchange gains                                          |   |                              | (60,981    | )      |                              |   | (41,927 | ) |
| Non-cash consulting fees                                                   |   |                              | 230,427    |   |                              |   | 116,364 |   |
| Changes in operating assets and liabilities:                               |   |                              |       |   |                              |   |   |   |
| Decrease (Increase) in other receivables                                   |   |                              | 11,531     |   |                              |   | 745 |   |
| Decrease (Increase) in deferred project cost                               |   |                              | 24,990     |   |                              |   | (24,990 | ) |
| Decrease (Increase) in prepaid expenses and deposits                       |   |                              | 18,357     |   |                              |   | (145,846 | ) |
| (Decrease) in deferred revenue                                             |   |                              | (24,990    | )      |                              |   | - |   |
| Increase (Decrease) in accounts payable and accrued liabilities            |   |                              | 204,885    |   |                              |   | (182,045 | ) |
| NET CASH USED IN OPERATING ACTIVITIES                                      |   |                              | (3,552,762 | )      |                              |   | (2,726,435 | ) |
|                                                                       |   |                              |       |   |                              |   |   |   |
| CASH FLOWS FROM INVESTING ACTIVITIES:                                      |   |                              |       |   |                              |   |   |   |
| Purchase of equipment                                                      |   |                              | (225,033   | )      |                              |   | (39,591 | ) |
| CASH USED IN BY INVESTING ACTIVITIES                                       |   |                              | (225,033   | )      |                              |   | (39,591 | ) |
|                                                                       |   |                              |       |   |                              |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES:                                      |   |                              |       |   |                              |   |   |   |
| Proceeds from issuance of common stock                                     |   |                              | 2,663,272  |   |                              |   | 2,753,918 |   |
| Proceeds from short term loans payable                                     |   |                              | -          |   |                              |   | - |   |
| Proceeds from convertible promissory notes                                 |   |                              | 580,075    |   |                              |   | 241,097 |   |
| Proceeds from other convertible notes ($272,712 from related parties)      |   |                              | 341,423    |   |                              |   | - |   |
| Repayment of loans payable                                                 |   |                              | (53,540    | )      |                              |   | - |   |
| CASH PROVIDED BY FINANCING ACTIVITIES                                      |   |                              | 3,531,230  |   |                              |   | 2,995,015 |   |
|                                                                       |   |                              |       |   |                              |   |   |   |
| Effect of exchange rate changes on cash                                    |   |                              | 1,224      |   |                              |   | (6,098 | ) |
|                                                                       |   |                              |       |   |                              |   |   |   |
| NET (DECREASE) INCREASE IN CASH                                            |   |                              | (245,341   | )      |                              |   | 222,891 |   |
| CASH                                                                       |   |                              |       |   |                              |   |   |   |
|  Beginning of period                                                  |   |                              | 250,339    |   |                              |   | 27,448 |   |
|  End of period                                                        |   | $                                 | 4,998      |   |                              | $      | 250,339 |   |
|                                                                       |   |                              |       |   |                              |   |   |   |
| SUPPLEMENTAL CASH FLOW INFORMATION:                                        |   |                              |       |   |                              |   |   |   |
| Income Tax paid                                                            |   | $                                 | -          |   |                              | $      | - |   |
| Interest paid                                                              |   | $                                 | -          |   |                              | $      | 27,477 |   |
| SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES       |   |
| Conversion of loans payable into common shares                             |   | $                                 | -          |   |                              | $      | 27,200 |   |
| Note issued for settlement of Accounts Payable                             |   | $                                 | 18,610     |   |                              | $      | - |   |
| Short term loan transferred to convertible note                            |   | $                                 | 22,977     |   |                              | $      | - |   |
| Accounts payable for equipment                                             |   | $                                 | 244,243    |   |                              | $      | 64,490 |   |
| Initial debt discount on convertible promissory notes                      |   | $                                 | 607,510    |   |                              | $      | 241,096 |   |
| Stock issued for settlement of accounts payable                            |   | $                                 | 171,362    |   |                              | $      | - |   |
| Conversion of promissory notes into common shares                          |   | $                                 | 1,312,918  |   |                              | $      | - |   |

----

----

----

----

----

|   | • | Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);                                       |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |    |                                                                                                                                                                                                |
|   | • | Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and                              |
|   |    |                                                                                                                                                                                                |
|   | • | Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives). |
| December 31, 2015    |   |    |   |   |    |   |   |    |   |   |    |   |
|----------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|---------|--------|
|                 |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total   |   |
| Liabilities:         |   |    |   |   |    |   |   |    |   |   |    |   |
| Derivative liability |   | $       | -      |   |    | $      | -      |    |   | $      | 210,834 |   |   | $ | 210,834 |   |
| December 31, 2014      |   |    |   |   |    |   |   |    |   |   |    |   |
|------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|---------|--------|
|                   |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total   |   |
| Liabilities:           |   |    |   |   |    |   |   |    |   |   |    |   |
| Derivative liabilities |   | $       | -      |   |    | $      | -      |    |   | $      | 336,390 |   |   | $ | 336,390 |   |

----

----

----

----

|                       |   |               |       |   | Weighted Average |   |
|----------------------------|--------|--------------------|------------|--------|------------------|--------|
|                       |   | Number of Warrants |       |   | Exercise Price   |   |
| Balance, December 31, 2013 |   |               | 1,580,000  |   |             | $      | 0.50 |   |
| Granted                    |   |               | -          |   |             |   | - |   |
| Expired                    |   |               | (1,580,000 | )      |             |   | - |   |
| Balance, December 31, 2014 |   |               | -          |   |             | $      | - |   |
| Granted                    |   |               | -          |   |             |   |   |   |
| Balance, December 31, 2015 |   |               | -          |   |             | $      | - |   |

----

|                                         |   | 2015   |     |   | 2014   |   |
|----------------------------------------------|--------|--------|----------|--------|--------|--------|
|                                         |   |   |     |   |   |   |
| Computer equipment under capital lease       |   | $      | 223,683  |   |   | $      | 223,683 |   |
| Nexus computer equipment under capital lease |   |   | 42,023   |   |   |   | 42,023 |   |
| Computer equipment                           |   |   | 50,724   |   |   |   | 39,338 |   |
| Computer software                            |   |   | 37,210   |   |   |   | 9,577 |   |
| Hardware & Installation                  |   |   | 10,128   |   |   |   | - |   |
| Office furniture and equipment               |   |   | 27,739   |   |   |   | 24,796 |   |
| Leasehold improvement                        |   |   | 55,072   |   |   |   | 30,370 |   |
| Medical Equipment                            |   |   | 13,274   |   |   |   | - |   |
| Clinical Command Center                      |   |   | 15,790   |   |   |   | - |   |
| Infrastructure                               |   |   | 7,911    |   |   |   | - |   |
|                                         |   |   |     |   |   |   |   |   |
| Total Equipment                              |   |   | 483,554  |   |   |   | 369,787 |   |
| Less accumulated depreciation                |   |   | (348,003 | )      |   |   | (271,546 | ) |
|                                         |   |   |     |   |   |   |   |   |
| Equipment – net                        |   | $      | 135,551  |   |   | $      | 98,241 |   |

----

----

| Original Face amount        |   | Interest rate | Due date | Conversion price per share |
|-----------------------------|--------|---------------|----------|----------------------------|
|                        |   |          |     |        |
| Promissory note of $125,000 |   |          | 8%       | December 1, 2015           | 75% of average of the previous two lowest tradingdays over the last 15 trading days |
| Promissory note of $100,000 |   |          | 10%      | December 21, 2015          | 65% of lowest trading day overthe last 15 trading days |
| Promissory note of $50,000  |   |          | 8%       | October 5, 2015            | 60% of the lowest trading price overthe last 15 trading days |
| Promissory note of $87,500  |   |          | 8%       | January 15, 2016           | 70% of average of two lowest closing bid price overthe last 15 trading days |
| Promissory note of $60,000  |   |          | 12%      | February 3, 2017           | 60% of the lowest trading price overthe last 25 trading days |
| Promissory note of $50,000  |   |          | 12%      | February 3, 2017           | 65% of the lowest trading price overthe last 25 trading days |
| Promissory note of $55,000  |   |          | 8%       | July 9, 2017               | 65% of the lowest trading price overthe last 20 trading days |
| Promissory note of $55,000  |   |          | 8%       | February 5, 2016           | 60% of the lowest trading price overthe last 15 trading days |
| Promissory note of $40,000  |   |          | 8%       | July 13, 2016              | 60% of the lowest trading price overthe last 15 trading days |
|                                 |   | 2015   |     |   | 2014   |   |
|--------------------------------------|--------|--------|----------|--------|--------|--------|
| Balance as at Beginning of Period    |   | $      | 16,175   |   |   | $      | - |   |
| New convertible promissory notes     |   |   | 633,611  |   |   |   | 265,000 |   |
| Original issue discount              |   |   | (53,536  | )      |   |   | (23,904 | ) |
| Penalties                            |   |   | 114,914  |   |   |   | - |   |
| Derivative liabilities               |   |   | (607,510 | )      |   |   | (241,096 | ) |
| Converted into shares                |   |   | (654,641 | )      |   |   | - |   |
| Amortization of debt discount        |   |   | 780,364  |   |   |   | 16,175 |   |
| Balance as at end of period          |   |   | 229,377  |   |   |   | 16,175 |   |
| Convertible notes – short term |   |   | (204,826 | )      |   |   | (16,175 | ) |
| Convertible notes – long term  |   | $      | 24,551   |   |   | $      | - |   |

----

| • | The notes convert with an initial conversion price of 55%-75% of the average or low of the close or bid prices over the 15-15 previous days. |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------|

| • | The projected annual volatility curve for each valuation period was based on the historical annual volatility of the company in the range 238% - 278%. |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | The holder would automatically convert the note at the maximum of 2 times the conversion price. |
|---------|-------------------------------------------------------------------------------------------------|

| • | Full Reset events are projected to occur quarterly generating a projected conversion prices at 125% of market. |
|---------|----------------------------------------------------------------------------------------------------------------|

|                                                       |   | 2015   |     |   | 2014   |   |
|------------------------------------------------------------|--------|--------|----------|--------|--------|--------|
|                                                       |   |   |     |   |   |   |
| Fair value as at beginning of period                       |   | $      | 336,390  |   |   | $      | - |   |
| New promissory notes                                       |   |   | 607,510  |   |   |   | 386,187 |   |
| Elimination associated with conversion of promissory notes |   |   | (635,176 | )      |   |   | - |   |
| Change in fair value (gain)                                |   |   | (97,890  | )      |   |   | (49,797 | ) |
| Fair value as at end of period                             |   | $      | 210,834  |   |   | $      | 336,390 |   |

----

|                                                                                |   | 2015   |    |   | 2014   |   |
|-------------------------------------------------------------------------------------|--------|--------|---------|--------|--------|--------|
|                                                                                |   |   |    |   |   |   |
| Promissory note bearing interest at 10% per annum, due Nov. 15, 2015                |   | $      | -       |   |   | $      | 25,020 |   |
| Convertible promissory note bearing interest at 15% per annum –third party    |   |   | 105,395 |   |   |   | - |   |
| Convertible promissory note bearing interest at 15% per annum – Related Party |   |   | 272,712 |   |   |   | - |   |
| Non-interest bearing short term funding from third parties                          |   |   | 15,730  |   |   |   | 13,535 |   |
|                                                                                |   | $      | 393,837 |   |   | $      | 38,555 |   |

----

|                                              |   | 2015   |       |   | 2014   |   |
|---------------------------------------------------|--------|--------|------------|--------|--------|--------|
| Net loss for the year                             |   | $      | (8,964,960 | )      |   | $      | (4,209,038 | ) |
| Effective statutory rate                          |   |   | 34         | %      |   |   | 34 | % |
| Expected tax recovery                             |   | $      | (3,048,086 | )      |   | $      | (1,431,073 | ) |
| Net effects of non deductible and allowable items |   |   | 1,742,542  |   |   |   | 29,697 |   |
| Change in valuation allowance                     |   |   | 1,305,544  |   |   |   | 1,401,376 |   |
|                                              |   | $      | -          |   |   | $      | - |   |
|                                            |   | 2015   |       |   | 2014   |   |
|-------------------------------------------------|--------|--------|------------|--------|--------|--------|
| Net operating loss carry forward                |   | $      | 4,779,729  |   |   | $      | 3,710,244 |   |
| Equipment                                       |   |   | 118,771    |   |   |   | 9,335 |   |
| Valuation allowance                             |   |   | (4,898,500 | )      |   |   | (3,719,579 | ) |
| Deferred tax assets, net of valuation allowance |   | $      | -          |   |   | $      | - |   |

----

| 2016   |   | $ | 201,215 |   |
|--------|--------|---|---------|--------|
|   |   | $ | 201,215 |   |
| 2014   |   | $      | 122,432 |   |
|--------|--------|--------|---------|--------|
| 2015   |   |   | 209,965 |   |
|   |   | $      | 332,397 |   |

----

| - | equal to $20,000,000, payable as to an advance of $300,000 immediately after the loan agreement for the Kallo MobileCare and RuralCare program is signed by the Minister of Finance of the Republic of Guinea and the remainder within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. |
|---|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| - | equal to $4,000,000, payable within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. In addition, a performance incentive payment of $1,000,000 will be payable to three persons related to the third party in accordance to the same terms of payment described herein. |
|---|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
|---------|---------------------------------------------------------------------------------------|

----

| 1.     | The application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements, and neither a written report was provided to us nor oral advice was provided that MaloneBailey, LLP concluded was an important factor considered by us in reaching a decision as to the accounting, auditing or financial reporting issue; or |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 2.     | Any matter that was either subject of disagreement or event, as defined in Item 304(a)(1)(iv)(A) of Regulation S-K and the related instruction to Item 304 of Regulation S-K, or a reportable event, as that term is explained in Item 304(a)(1)(iv)(A) of Regulation S-K.                                                                                                                                                          |

----

| * | Lack of segregation of duties                                                                                                                                                                                              |
|---|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| * | Insufficient controls over the financial close process and preparation of the financial statements identified by the auditors during the audit of the company's financial statements for the year ended December 31, 2015. |

| Name and Address                                            | Age    | Position(s)                                          |
|-------------------------------------------------------------|--------|------------------------------------------------------|
|                                                        |   |                                                 |
| John Cecil                                                  | 52     | President, Chairman of the Board of Directors, Chief |
| 675 Cochrane Drive,West Tower, Suite 630Markham, ON L3R 0B8 |   | Executive Officer and Chief Financial Officer        |
|                                                        |   |                                                 |

----

| Lloyd A. Chiotti                      | 67     | Chief Operating Officer and Director |
|---------------------------------------|--------|--------------------------------------|
| 31 Sisman AvenueAurora, ON, L4G 6R9   |   |                                 |
|                                  |   |                                 |
| Samuel R Baker                        | 80     | Secretary and a Director             |
| 89 Shawnee CircleToronto, ON, M2H 2X9 |   |                                 |

----

| 1. | A petition under the Federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing; |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | The subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities; |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | i) | Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator,  floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity; |
|--|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | ii) | Engaging in any type of business practice; or |
|--|-----|-----------------------------------------------|

|  | iii) | Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws; |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | The subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph 3.i in the preceding paragraph or to be associated with persons engaged in any such activity; |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | Was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated; |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | Was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated; |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7. | Was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of: |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | i) | Any Federal or State securities or commodities law or regulation; or |
|--|----|----------------------------------------------------------------------|

|  | ii) | Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | iii) | Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or |
|--|------|----------------------------------------------------------------------------------------------------------|

----

| 8. | Was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (a)                                   | (b)    | (c)       | (d)      | (e)               | (f)             | (g)                                     | (h)                                                                     | (i)                      | (j)       |
|---------------------------------------|--------|-----------|----------|-------------------|-----------------|-----------------------------------------|-------------------------------------------------------------------------|--------------------------|-----------|
| Name and PrincipalPosition [1]        | Year   | Salary($) | Bonus($) | StockAwards($)[1] | OptionAwards($) | Non-EquityIncentive PlanCompensation(S) | Change inPension Value &NonqualifiedDeferredCompensationEarnings($) | All OtherCompensation($) | Totals($) |
| John Cecil                            | 2015   | 132,902   | 0        | 1,950,000         | 0               | 0                                       | 0                                                                       | 0                        | 2,082,902 |
| Chairman & CEO                    | 2014   | 160,941   | 0        | 412,785           | 0               | 0                                       | 0                                                                       | 43,154                   | 616,880   |
|                                  |   |      |     |              |            |                                    |                                                                    |                     |      |
| Vince Leitao                          | 2015   | 29,644    | 0        | 0                 | 0               | 0                                       | 0                                                                       | 0                        | 29,644    |
| Former President(resigned 02/29/2016) | 2014   | 160,941   | 0        | 60,796            | 0               | 0                                       | 0                                                                       | 0                        | 221,737   |
|                                  |   |      |     |              |            |                                    |                                                                    |                     |      |
| Samuel Baker                          | 2015   | 0         | 0        | 480,000           | 0               | 0                                       | 0                                                                       | 0                        | 480,000   |
| Secretary                             | 2014   | 0         | 0        | 150,000           | 0               | 0                                       | 0                                                                       | 0                        | 150,000   |
|                                  |   |      |     |              |            |                                    |                                                                    |                     |      |
| Lloyd Chiotti                         | 2015   | 0         | 0        | 1,200,000         | 0               | 0                                       | 0                                                                       | 0                        | 1,200,000 |
| Director & EVP                    | 2014   | 0         | 0        | 15,199            | 0               | 0                                       | 0                                                                       | 0                        | 15,199    |

| [1] | During the year ended December 31, 2015, 2,662,500,000 common shares were issued to directors and officers for a total amount of $3,630,000 of which $NIL was contributed as cash by them and $3,630,000 was granted to them as stock-based compensation. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·     | John Cecil – 1,560,000,000 common shares issued as compensation valued at $1,950,000 |
|--------------------------------|--------------------------------------------------------------------------------------------|

| · | Samuel Baker - 315,000,000 common shares issued as compensation valued at $480,000 |
|--------|------------------------------------------------------------------------------------|

| · | Lloyd Chiotti – 787,500,000 common shares issued as compensation valued at $1,200,000 |
|--------|---------------------------------------------------------------------------------------------|

----

| ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT. |
|----------|-----------------------------------------------------------------|

| Name and AddressBeneficial Owner [1]               | Number ofCommonShares Owned | Percentage ofOwnership | Number ofPreferredShares Owned | Percentage ofOwnership |
|----------------------------------------------------|-----------------------------|------------------------|--------------------------------|------------------------|
| John Cecil [2]                                     | 1,651,612,857               | 29.24%                 | 70,000,000                     | 73.69%                 |
| 15 Allstate Parkway, Suite 600Markham, ON L3R 3B4  |                        |                   |                           |                   |
|                                               |                        |                   |                           |                   |
| Lloyd Chiotti                                      | 827,546,891                 | 14.65%                 | 5,000,000                      | 5.26%                  |
| 31 Sisman AvenueAurora, ON, L4G 6R9                |                        |                   |                           |                   |
|                                               |                        |                   |                           |                   |
| Samuel Baker [3]                                   | 328,213,850                 | 5.81%                  | -                              | -                      |
| 255 Duncan Mill Road, Unit 504Toronto, ON, M3B 3H9 |                        |                   |                           |                   |
|                                               |                        |                   |                           |                   |
| All Officers and Directors as a Group (3 people)   | 2,807,33,598                | 49.70%                 | 75,000,000                     | 78.95%                 |
|                                               |                        |                   |                           |                   |
| Vince Leitao [4]                                   | 56,637,845                  | 1.00%                  | 20,000,000                     | 21.05%                 |
| 15 Allstate Parkway, Suite 600Markham, ON L3R 3B4  |                        |                   |                           |                   |

| [1] | The persons named above may be deemed to be a "parent" and "promoter" of our company, within the meaning of such terms under the Securities Act of 1933, as amended, by virtue of his/its direct and indirect stock holdings. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| [2] | Includes 17,600,000 shares of common stock owned by family members of John Cecil.                                                                                                                                             |
| [3] | Includes 410,000 shares of common stock owned by family members of Samuel Baker.                                                                                                                                              |
| [4] | Includes 15,000,000 shares of common stock owned by family members of Vince Leitao.                                                                                                                                           |
| [5] | Each preferred share is entitled to 100 votes.                                                                                                                                                                                |

----

|   | 2015 | $ | 149,446 |   | MaloneBailey LLP              |
|--------|------|---|---------|--------|-------------------------------|
|   | 2014 | $ | 106,116 |   | MaloneBailey LLP              |
|   | 2014 | $ | 65,557  |   | Schwartz Levitsky Feldman LLP |

|   | 2015 | $ |  0 |   | MaloneBailey, LLP             |
|--------|------|---|---------|--------|-------------------------------|
|   | 2014 | $ |  0 |   | MaloneBailey LLP              |
|   | 2014 | $ | 0       |   | Schwartz Levitsky Feldman LLP |

|   | 2015 | $ | 0 |   | MaloneBailey, LLP             |
|--------|------|---|---|--------|-------------------------------|
|   | 2014 | $ | 0 |   | MaloneBailey LLP              |
|   | 2014 | $ | 0 |   | Schwartz Levitsky Feldman LLP |

----

|   | 2015 | $ | 0       |   | MaloneBailey LLP              |
|--------|------|---|---------|--------|-------------------------------|
|   | 2014 | $ |  0 |   | MaloneBailey LLP              |
|   | 2014 | $ | 0       |   | Schwartz Levitsky Feldman LLP |

----

|    |                                                                                | Incorporated by reference | Filed    |
|---------|-------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                | Form                      | Date     | Number | herewith |
|    |                                                                                |                      |     |   |   |
| 2.1     | Articles of Merger.                                                                 | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                |                      |     |   |   |
| 3.1     | Articles of Incorporation.                                                          | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                |                      |     |   |   |
| 3.2     | Bylaws.                                                                             | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015).                                     | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                |                      |     |   |   |
| 4.1     | Specimen Stock Certificate.                                                         | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.1    | Option Agreement.                                                                   | SB-2                      | 3/05/07  | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.2    | Lease Agreement                                                                     | SB-2                      | 3/05/07  | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.3    | Agreement with Rophe Medical Technologies Inc. datedDecember 11, 2009.              | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                |                      |     |   |   |
| 10.4    | Amended Agreement with Rophe Medical Technologies Inc.dated December 18, 2009.      | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                |                      |     |   |   |
| 10.5    | Amended Agreement with Rophe Medical Technologies Inc.dated March 16, 2010.         | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                |                      |     |   |   |
| 10.6    | Investment Agreement with Kodiak Capital Group, LLC.                                | S-1                       | 10/29/14 | 10.6 |   |
|    |                                                                                |                      |     |   |   |
| 10.7    | Consulting Agreement with Ten Associate LLC.                                        | S-1                       | 5/24/10  | 10.7 |   |
|    |                                                                                |                      |     |   |   |
| 10.8    | Employment Agreement with Leonard Steinmetz.                                        | S-1                       | 5/24/10  | 10.8 |   |
|    |                                                                                |                      |     |   |   |
| 10..9   | Employment Agreement with Samuel Baker.                                             | S-1                       | 5/24/10  | 10.9 |   |
|    |                                                                                |                      |     |   |   |
| 10.10   | Employment Agreement with John Cecil.                                               | S-1                       | 5/24/10  | 10.10 |   |
|    |                                                                                |                      |     |   |   |
| 10.11   | Employment Agreement with Mary Kricfalusi.                                          | S-1                       | 5/24/10  | 10.11 |   |
|    |                                                                                |                      |     |   |   |
| 10.12   | Employment Agreement with Vince Leitao.                                             | S-1                       | 5/24/10  | 10.12 |   |
|    |                                                                                |                      |     |   |   |
| 10.13   | Amended Consulting Agreement with Ten Associate LLCdated October 5, 2010.           | 8-K                       | 10/14/10 | 10.13 |   |
|    |                                                                                |                      |     |   |   |
| 10.14   | Agreement with Jarr Capital Corp.                                                   | 8-K                       | 11/17/10 | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.15   | Agreement with Mary Kricfalusi.                                                     | 8-K                       | 11/19/10 | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.16   | Agreement with Herb Adams.                                                          | 8-K                       | 11/19/10 | 10.2 |   |
|    |                                                                                |                      |     |   |   |
| 10.17   | North American Authorized Agency Agreement withAdvanced Software Technologies, Inc. | 8-K                       | 12/16/10 | 10.1 |   |

----

| 10.18  | Amended Agreement with Jarr Capital Corp.                                                                                             | 8-K     | 2/22/11  | 10.1   |   |
|--------|---------------------------------------------------------------------------------------------------------------------------------------|---------|----------|--------|--------|
|   |                                                                                                                                  |    |     |   |   |
| 10.19  | Termination of Employment Agreement with John Cecil.                                                                                  | 8-K     | 2/22/11  | 10.2   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.20  | Termination of Employment Agreement with Vince Leitao.                                                                                | 8-K     | 2/22/11  | 10.3   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.21  | Termination of Employment Agreement with Samuel Baker.                                                                                | 8-K     | 2/22/11  | 10.4   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.22  | Services Agreement with Buchanan Associates ComputerConsulting Ltd.                                                                   | 10-K    | 5/18/11  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.23  | Equipment Lease Agreement with Buchanan AssociatesComputer Consulting Ltd.                                                            | 10-K    | 5/18/11  | 10.2   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.24  | Agreement with Mansfield Communications Inc.                                                                                          | 10-K    | 5/18/11  | 10.3   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.25  | Agreement with Watt International Inc.                                                                                                | 10-K    | 5/18/11  | 10.4   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.26  | Pilot EMR Agreement with Nexus Health Management Inc.                                                                                 | 10-K    | 5/18/11  | 10.5   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.27  | 2011 Non-Qualified Stock Option Plan.                                                                                                 | S-8     | 6/27/11  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.28  | Multimedia Contractual Agreement with David Miller.                                                                                   | 8-K     | 10/28/11 | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.29  | Strategic Alliance Agreement with Petro Data ManagementServices Limited and Gateway Global Fabrication Ltd.                           | 8-K     | 11/02/11 | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.30  | Independent Contractor Agreement with Savers Drug Mart.                                                                               | 8-K     | 1/26/12  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.31  | 2012 Non-Qualified Stock Option Plan.                                                                                                 | S-8     | 9/06/12  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.32  | Memorandum of Offering with Ministry of Health of Republicof Ghana.                                                                   | S-1/A-3 | 6/26/13  | 10.32  |   |
|   |                                                                                                                                  |    |     |   |   |
| 14.1   | Code of Ethics.                                                                                                                       | 10-K    | 4/15/08  | 14.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.1   | Letter from Kempisty & Company                                                                                                    | 8-K     | 10/27/09 | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.2   | Letter from MaloneBailey, LLP                                                                                                         | 8-K     | 3/02/11  | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.3   | Letter from Schwartz Levitsky Feldman LLP                                                                                             | 8-K     | 6/11/14  | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 21.1   | List of Subsidiary Companies.                                                                                                         | 10-K    | 3/31/10  | 21.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 23.1   | Consent of MaloneBailey LLP.                                                                                                          |    |     |   | X      |
|   |                                                                                                                                  |    |     |   |   |
| 31.1   | Certification of Principal Executive Officer and PrincipalFinancial Officer pursuant to Section 302 of the Sarbanes-OxleyAct of 2002. |    |     |   | X      |
|   |                                                                                                                                  |    |     |   |   |
| 32.1   | Certification of Chief Executive Officer and Chief FinancialOfficer pursuant to Section 906 of the Sarbanes-Oxley Act of2002.         |    |     |   | X      |

----

|    |                                          |   |    |   |   |
|---------|-----------------------------------------------|--------|---------|--------|--------|
| 99.1    | Audit Committee Charter.                      | 10-K   | 4/15/08 | 99.1   |   |
|    |                                          |   |    |   |   |
| 99.2    | Disclosure Committee Charter.                 | 10-K   | 4/15/08 | 99.2   |   |
|    |                                          |   |    |   |   |
| 101.INS | XBRL Instance Document.                       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema.       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations. |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions.  |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels.       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation. |   |    |   |   |

----

|   | KALLO INC. |
|--------|------------|
|   |       |
|   | BY:        | JOHN CECIL |
|   |       | John Cecil |
|   |       | President, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Chairman of Board of Directors |
|   |       |   |

| Signature        | Title                                                                                        | Date           |
|------------------|----------------------------------------------------------------------------------------------|----------------|
|             |                                                                                         |           |
| JOHN CECIL       | President, Principal Executive Officer,                                                      | April 14, 2015 |
| John Cecil       | Principal Financial Officer, Principal Accounting Officer and Chairman of Board of Directors |           |
|             |                                                                                         |           |
| SAMUEL BAKER     | Corporate Secretary and member of                                                            | April 14, 2015 |
| Samuel Baker     | the Board of Directors                                                                       |           |
|             |                                                                                         |           |
| LLOYD A. CHIOTTI | Chief Operating Officer and member of the                                                    | April 14, 2015 |
| Lloyd A. Chiotti | Board of Directors                                                                           |           |

----

|    |                                                                                | Incorporated by reference | Filed    |
|---------|-------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                | Form                      | Date     | Number | herewith |
|    |                                                                                |                      |     |   |   |
| 2.1     | Articles of Merger.                                                                 | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                |                      |     |   |   |
| 3.1     | Articles of Incorporation.                                                          | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                |                      |     |   |   |
| 3.2     | Bylaws.                                                                             | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015).                                     | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                |                      |     |   |   |
| 4.1     | Specimen Stock Certificate.                                                         | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.1    | Option Agreement.                                                                   | SB-2                      | 3/05/07  | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.2    | Lease Agreement                                                                     | SB-2                      | 3/05/07  | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.3    | Agreement with Rophe Medical Technologies Inc. datedDecember 11, 2009.              | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                |                      |     |   |   |
| 10.4    | Amended Agreement with Rophe Medical Technologies Inc.dated December 18, 2009.      | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                |                      |     |   |   |
| 10.5    | Amended Agreement with Rophe Medical Technologies Inc.dated March 16, 2010.         | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                |                      |     |   |   |
| 10.6    | Investment Agreement with Kodiak Capital Group, LLC.                                | S-1                       | 10/29/14 | 10.6 |   |
|    |                                                                                |                      |     |   |   |
| 10.7    | Consulting Agreement with Ten Associate LLC.                                        | S-1                       | 5/24/10  | 10.7 |   |
|    |                                                                                |                      |     |   |   |
| 10.8    | Employment Agreement with Leonard Steinmetz.                                        | S-1                       | 5/24/10  | 10.8 |   |
|    |                                                                                |                      |     |   |   |
| 10..9   | Employment Agreement with Samuel Baker.                                             | S-1                       | 5/24/10  | 10.9 |   |
|    |                                                                                |                      |     |   |   |
| 10.10   | Employment Agreement with John Cecil.                                               | S-1                       | 5/24/10  | 10.10 |   |
|    |                                                                                |                      |     |   |   |
| 10.11   | Employment Agreement with Mary Kricfalusi.                                          | S-1                       | 5/24/10  | 10.11 |   |
|    |                                                                                |                      |     |   |   |
| 10.12   | Employment Agreement with Vince Leitao.                                             | S-1                       | 5/24/10  | 10.12 |   |
|    |                                                                                |                      |     |   |   |
| 10.13   | Amended Consulting Agreement with Ten Associate LLCdated October 5, 2010.           | 8-K                       | 10/14/10 | 10.13 |   |
|    |                                                                                |                      |     |   |   |
| 10.14   | Agreement with Jarr Capital Corp.                                                   | 8-K                       | 11/17/10 | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.15   | Agreement with Mary Kricfalusi.                                                     | 8-K                       | 11/19/10 | 10.1 |   |
|    |                                                                                |                      |     |   |   |
| 10.16   | Agreement with Herb Adams.                                                          | 8-K                       | 11/19/10 | 10.2 |   |
|    |                                                                                |                      |     |   |   |
| 10.17   | North American Authorized Agency Agreement withAdvanced Software Technologies, Inc. | 8-K                       | 12/16/10 | 10.1 |   |

----

| 10.18  | Amended Agreement with Jarr Capital Corp.                                                                                             | 8-K     | 2/22/11  | 10.1   |   |
|--------|---------------------------------------------------------------------------------------------------------------------------------------|---------|----------|--------|--------|
|   |                                                                                                                                  |    |     |   |   |
| 10.19  | Termination of Employment Agreement with John Cecil.                                                                                  | 8-K     | 2/22/11  | 10.2   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.20  | Termination of Employment Agreement with Vince Leitao.                                                                                | 8-K     | 2/22/11  | 10.3   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.21  | Termination of Employment Agreement with Samuel Baker.                                                                                | 8-K     | 2/22/11  | 10.4   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.22  | Services Agreement with Buchanan Associates ComputerConsulting Ltd.                                                                   | 10-K    | 5/18/11  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.23  | Equipment Lease Agreement with Buchanan AssociatesComputer Consulting Ltd.                                                            | 10-K    | 5/18/11  | 10.2   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.24  | Agreement with Mansfield Communications Inc.                                                                                          | 10-K    | 5/18/11  | 10.3   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.25  | Agreement with Watt International Inc.                                                                                                | 10-K    | 5/18/11  | 10.4   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.26  | Pilot EMR Agreement with Nexus Health Management Inc.                                                                                 | 10-K    | 5/18/11  | 10.5   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.27  | 2011 Non-Qualified Stock Option Plan.                                                                                                 | S-8     | 6/27/11  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.28  | Multimedia Contractual Agreement with David Miller.                                                                                   | 8-K     | 10/28/11 | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.29  | Strategic Alliance Agreement with Petro Data ManagementServices Limited and Gateway Global Fabrication Ltd.                           | 8-K     | 11/02/11 | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.30  | Independent Contractor Agreement with Savers Drug Mart.                                                                               | 8-K     | 1/26/12  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.31  | 2012 Non-Qualified Stock Option Plan.                                                                                                 | S-8     | 9/06/12  | 10.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 10.32  | Memorandum of Offering with Ministry of Health of Republicof Ghana.                                                                   | S-1/A-3 | 6/26/13  | 10.32  |   |
|   |                                                                                                                                  |    |     |   |   |
| 14.1   | Code of Ethics.                                                                                                                       | 10-K    | 4/15/08  | 14.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.1   | Letter from Kempisty & Company                                                                                                    | 8-K     | 10/27/09 | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.2   | Letter from MaloneBailey, LLP                                                                                                         | 8-K     | 3/02/11  | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 16.3   | Letter from Schwartz Levitsky Feldman LLP                                                                                             | 8-K     | 6/11/14  | 16.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 21.1   | List of Subsidiary Companies.                                                                                                         | 10-K    | 3/31/10  | 21.1   |   |
|   |                                                                                                                                  |    |     |   |   |
| 23.1   | Consent of MaloneBailey LLP.                                                                                                          |    |     |   | X      |
|   |                                                                                                                                  |    |     |   |   |
| 31.1   | Certification of Principal Executive Officer and PrincipalFinancial Officer pursuant to Section 302 of the Sarbanes-OxleyAct of 2002. |    |     |   | X      |
|   |                                                                                                                                  |    |     |   |   |
| 32.1   | Certification of Chief Executive Officer and Chief FinancialOfficer pursuant to Section 906 of the Sarbanes-Oxley Act of2002.         |    |     |   | X      |

----

|    |                                          |   |    |   |   |
|---------|-----------------------------------------------|--------|---------|--------|--------|
| 99.1    | Audit Committee Charter.                      | 10-K   | 4/15/08 | 99.1   |   |
|    |                                          |   |    |   |   |
| 99.2    | Disclosure Committee Charter.                 | 10-K   | 4/15/08 | 99.2   |   |
|    |                                          |   |    |   |   |
| 101.INS | XBRL Instance Document.                       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema.       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations. |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions.  |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels.       |   |    |   |   |
|    |                                          |   |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation. |   |    |   |   |